Key role of mast cells and their major secretory products in inflammatory bowel disease-中国期刊网

摘要 Historically,mastcellswereknownasakeycelltypeinvolvedintypeIhypersensitivity.Untillasttwodecades,thiscelltypewasrecognizedtobewidelyinvolvedinanumberofnon-allergicdiseasesincludinginflammatoryboweldisease(IBD).MarkedlyincreasednumbersofmastcellswereobservedinthemucosaoftheileumandcolonofpatientswithIBD,whichwasaccompaniedbygreatchangesofthecontentinmastcellssuchasdramaticallyincreasedexpressionofTNFα,IL-16andsubstanceP.TheevidenceofmastcelldegranulationwasfoundinthewallofintestinefrompatientswithIBDwithimmunohistochemistrytechnique.ThehighlyelevatedhistamineandtryptaselevelsweredetectedinmucosaofpatientswithIBD,stronglysuggestingthatmastcelldegranulationisinvolvedinthepathogenesisofIBD.However,littleisknownoftheactionsofhistamine,tryptase,chymaseandcarboxypeptidaseinIBD.Overthelastdecade,heparinhasbeenusedtotreatIBDinclinicalpractice.Thelowmolecularweightheparin(LMWH)waseffectiveasadjuvanttherapy,andthepatientsshowedgoodclinicalandlaboratoryresponsewithnoseriousadverseeffects.TherolesofPGD2,LTC4,PAFandmastcellcytokinesinIBDwerealsodiscussed.Recently,aseriesofexperimentswithdispersedcolonmastcellssuggestedthereshouldbeatleasttwopathwaysinmanformastcellstoamplifytheirownactivation-degranulationsignalsinanautocrineorparacrinemanner.Thehypothesisisthatmastcellsecretogoguesinducemastcelldegranulation,releasehistamine,thenstimulatetheadjacentmastcellsorpositivelyfeedbacktofurtherstimulateitshostmastcellsthroughH1receptor.Whereasreleasedtryptaseactssimilarlytohistamine,butactivatesmastcellsthroughitsreceptorPAR-2.Theconnectionsbetweencurrentanti-IBDtherapiesorpotentialtherapiesforIBDwithmastcellswerediscussed,implicatingfurtherthatmastcellisakeycelltypethatisinvolvedinthepathogenesisofIBD.Inconclusion,whilepathoge

1Mike G Laukoetter;Porfirio Nava;Asma Nusrat. Role of the intestinal barrier in inflammatory bowel disease.消化系统,2008-03.
2Maria Vutcovici;Paul Brassard;Alain Bitton. Inflammatory bowel disease and airway diseases.消化系统,2016-12.
3C Buechler. Chemerin, a novel player in inflammatory bowel disease.免疫学,2014-04.
4Zhen-Yang Gu,Wen-Long Pei,Yi Zhang,Jun Zhu,Lei Li,Zhan Zhang. Akkermansia muciniphila in inflammatory bowel disease and colorectal cancer.医药卫生,2021-12.
5Robert E Roses John L Rombeau. Recent trends in the surgical management of inflammatory bowel disease.消化系统,2008-03.
6Ali Salaritabar;Behrad Darvishi;Farzaneh Hadjiakhoondi;Azadeh Manayi;Antoni Sureda;Seyed Fazel Nabavi;Leo R Fitzpatrick;Seyed Mohammad Nabavi;Anupam Bishayee. Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive review.消化系统,2017-12.
7Li Ji,Qian Jia-Ming. Artificial intelligence in inflammatory bowel disease: current status and opportunities.医药卫生,2020-08.
8Zhaoyang Zhao,Xinghui Ji,Ting Zhang,Qianqian Li,Cicilia Marcella,Quan Wen,Bota Cui,Faming Zhang. Washed microbiota transplantation improves the fertility of patients with inflammatory bowel disease.医药卫生,2022-12.
9Yan Peng-Guang,Li Jing-Nan. Advances in the understanding of the intestinal micro-environment and inflammatory bowel disease.医药卫生,2020-08.
10Xiaoyin Bai,Lingjuan Jiang,Gechong Ruan,Tingting Liu,Hong Yang. Helicobacter pylori may participate in the development of inflammatory bowel disease by modulating the intestinal microbiota.医药卫生,2022-12.

Key role of mast cells and their major secretory products in inflammatory bowel disease

来源期刊

相关推荐

同分类资源更多

相关关键词

Key role of mast cells and their major secretory products in inflammatory bowel disease

来源期刊

相关推荐

同分类资源 更多

相关关键词

同分类资源更多